Chiral separation of 10,11-dihydro-10, 11-trans-dihydroxycarbamazepine, a metabolite of carbamazepine with two asymmetric carbons, in human serum

J Chromatogr B Biomed Appl. 1996 Mar 3;677(2):325-30. doi: 10.1016/0378-4347(95)00454-8.

Abstract

Chiral separation of 10, 11-dihydro-10, 11-trans-dihydroxycarbamazepine (CBZ-diol), a metabolite of carbamazepine (CBZ) with two asymmetric carbons, in serum taken from epileptic patients receiving CBZ alone for a long period, was performed by high-performance liquid chromatography using a polysaccharide stationary phase with n-hexane-ethanol (75:25, v/v) as the mobile phase. The enantiomeric ratio (S,S-/R,R-CBZ-diol) was 10.74 +/- 1.13 (mean +/- S.D.), which could demonstrate the presence of the stereospecificity in the hydrolysis of 10, 11-dihydro-10, 11-epoxycarbamazepine (CBZ-epoxide) to CBZ-diol and/or in the conversion of CBZ-diol to some metabolite such as 9-hydroxymethyl-10-carbamoylacridan. This is the first paper to report the determination of each enantiomer and the enantiomeric ratio of CBZ-diol in serum of epileptic patients who received CBZ.

MeSH terms

  • Carbamazepine / analogs & derivatives*
  • Carbamazepine / blood
  • Carbamazepine / chemistry
  • Carbamazepine / therapeutic use
  • Chromatography, High Pressure Liquid
  • Epilepsy / blood
  • Epilepsy / drug therapy
  • Humans
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Spectrophotometry, Ultraviolet
  • Stereoisomerism

Substances

  • Carbamazepine
  • 10,11-dihydro-10,11-dihydroxy-5H-dibenzazepine-5-carboxamide